CYTK
Price
$31.29
Change
-$1.37 (-4.19%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
3.74B
71 days until earnings call
ROIV
Price
$10.91
Change
-$0.13 (-1.18%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
7.78B
35 days until earnings call
Interact to see
Advertisement

CYTK vs ROIV

Header iconCYTK vs ROIV Comparison
Open Charts CYTK vs ROIVBanner chart's image
Cytokinetics
Price$31.29
Change-$1.37 (-4.19%)
Volume$33.29K
Capitalization3.74B
Roivant Sciences
Price$10.91
Change-$0.13 (-1.18%)
Volume$66.58K
Capitalization7.78B
CYTK vs ROIV Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. ROIV commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and ROIV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (CYTK: $31.31 vs. ROIV: $10.91)
Brand notoriety: CYTK and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 86% vs. ROIV: 46%
Market capitalization -- CYTK: $3.74B vs. ROIV: $7.78B
CYTK [@Biotechnology] is valued at $3.74B. ROIV’s [@Biotechnology] market capitalization is $7.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than CYTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 5 bullish TA indicator(s).

  • CYTK’s TA Score: 4 bullish, 4 bearish.
  • ROIV’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а +4.37% price change this week, while ROIV (@Biotechnology) price change was +2.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.07%. For the same industry, the average monthly price growth was +10.40%, and the average quarterly price growth was -0.77%.

Reported Earning Dates

CYTK is expected to report earnings on Jul 31, 2025.

ROIV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+6.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.79B) has a higher market cap than CYTK($3.74B). ROIV YTD gains are higher at: -7.777 vs. CYTK (-33.440). ROIV has higher annual earnings (EBITDA): 4.1B vs. CYTK (-513.62M). ROIV has more cash in the bank: 5.15B vs. CYTK (938M). ROIV has less debt than CYTK: ROIV (100M) vs CYTK (791M). ROIV has higher revenues than CYTK: ROIV (123M) vs CYTK (19.2M).
CYTKROIVCYTK / ROIV
Capitalization3.74B7.79B48%
EBITDA-513.62M4.1B-13%
Gain YTD-33.440-7.777430%
P/E RatioN/A1.97-
Revenue19.2M123M16%
Total Cash938M5.15B18%
Total Debt791M100M791%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKROIV
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 21 days ago
78%
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
Bearish Trend 7 days ago
78%
Bearish Trend 8 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ACSI61.20N/A
N/A
American Customer Satisfaction ETF
BSMQ23.47-0.01
-0.04%
Invesco BulletShares 2026 Muncpl Bd ETF
FFC15.65-0.19
-1.20%
Flaherty & Crumrine Preferred and Income Securities Fund
SCHH20.81-0.56
-2.62%
Schwab US REIT ETF™
AAPB19.87-0.98
-4.70%
GraniteShares 2x Long AAPL Daily ETF

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with KRYS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-4.13%
KRYS - CYTK
47%
Loosely correlated
-3.70%
ACLX - CYTK
46%
Loosely correlated
+8.26%
IDYA - CYTK
46%
Loosely correlated
-2.45%
TRDA - CYTK
43%
Loosely correlated
-6.67%
ROIV - CYTK
43%
Loosely correlated
-1.18%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-1.18%
IMVT - ROIV
60%
Loosely correlated
-3.93%
ACLX - ROIV
54%
Loosely correlated
+8.26%
CRNX - ROIV
53%
Loosely correlated
-4.53%
KRYS - ROIV
51%
Loosely correlated
-3.70%
KYMR - ROIV
50%
Loosely correlated
-4.17%
More